GUGGENHEIM CAPITAL LLC - TRILLIUM THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 130 filers reported holding TRILLIUM THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.

Links
Filings
Quarter-by-quarter ownership
GUGGENHEIM CAPITAL LLC ownership history of TRILLIUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$1,271,000
+144.4%
72,367
+34.9%
0.01%
+166.7%
Q2 2021$520,000
-5.5%
53,652
+4.8%
0.00%
-25.0%
Q1 2021$550,000
+39.6%
51,197
+91.2%
0.00%
+100.0%
Q4 2020$394,000–26,782–0.00%–
 Download
Other shareholders

There were no reported owners of TRILLIUM THERAPEUTICS INC in Q1 2021.

NameSharesValueWeighting ↓
View complete list of TRILLIUM THERAPEUTICS INC shareholders